NRG HN009

Primary Category:

Radiation Oncology, Treatment Protocols

Disease Category:

Head and Neck, Head and Neck Metastatic

Status:

New, Open

Randomized Phase II/III Trial of Radiation with Cisplatin at 100 mg/m2 Every Three Weeks Versus Radiation with Weekly Cisplatin at 40 mg/m2 for Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)

NCT#05050162